Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,849,430
+$80,336 QoQ
Shares Held
385,298
-2.0% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#39
of 175 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. ABUS ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in ABUS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,849,430 | 385,298 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,769,094 | 393,132 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,429,502 | 505,094 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,293,149 | 505,099 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,387,963 | 449,179 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,463,486 | 419,337 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,375,718 | 420,709 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,616,634 | 419,905 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,413,916 | 457,578 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,126,185 | 436,506 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $968,102 | 387,241 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $797,471 | 392,843 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $903,538 | 392,843 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,190,314 | 392,843 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||